Predictive value of integrative epigenetic profiling in metastatic melanoma (MM) patients (p) treated with BRAF/MEK inhibitors (BMI) and chemotherapy (CT).
José Luís Manzano, Anna Martínez Cardús, María Teresa Fernández‐Figueras, Aram Boada, José Luis Cuadra‐Urteaga, Sebastián Morán, Cristina Bugés, María de los Llanos Gil, Laura Layos, Alberto Indacochea, Laia Martínez, Max Hardy, Iris Teruel, Eva Martinez‐Balibrea, Manel Esteller (2015). Predictive value of integrative epigenetic profiling in metastatic melanoma (MM) patients (p) treated with BRAF/MEK inhibitors (BMI) and chemotherapy (CT).. , 33(15_suppl), DOI: https://doi.org/10.1200/jco.2015.33.15_suppl.e20059.
